Open Access Social Media Guide for Pharma on Webicina.com! December 15, 2011
Posted by Dr. Bertalan Meskó in Pharma, Web 2.0, Webicina.3 comments
After months of hard, collaborative work, Webicina.com just published the first version of the open access guide for pharma about using social media. While drug companies, healthcare professionals and e-patients wait for FDA guidelines on social media, with an expert crowd (with special thanks to Dr. Felix Jackson from MedDigital), we created our own guidelines to serve as a basis for more detailed, extended guides.
You can download the PDF (14 pages) here! And see it on Slideshare:
Please feel free to download it, share it with your colleagues and join us to create an even more sophisticated second version which we can submit to the FDA. Give us feedback on Twitter through #pharmaSMguide!
The original Google Docs document contains more details, negative and positive social media-related pharma case studies as well.
Here are the Q&As about the project.
Pharma and the Super Mobile Revolution December 15, 2011
Posted by Dr. Bertalan Meskó in Mobile, Pharma.add a comment
I was asked to contribute to the Pharma and Super Mobile Dossier of Firstworldplus.com. I wrote about the pros and cons of using a Samsung Galaxy Tab in medicine and healthcare.
Our latest report, iPad and Smartphone: Pharma and the Super Mobile Revolution examines the rapid changes in mobile and tablet technology, including the trend by HCPs and the industry to use multiple devices to positively impact work flow and business operations. The report tracks how the industry is addressing training, security, consumerization of IT within organizations and advances such as HTML5-Flash and apps.
As a bonus, we’re also offering The Impact of iPads on Pharma: a Primer, which offers a complete examination of what the industry has learned about tablets and how the post-PC tablet is changing internal productivity, growth and sales.
You can buy the report here.
Social Media in Pharma Trailer October 10, 2011
Posted by Dr. Bertalan Meskó in Pharma, Video, Web 2.0.add a comment
The trailer to Social Media in Pharma, a thought leadership film where key players in healthcare and healthcare communication provide unique insights on the use of social media within the pharmaceutical industry has been published recently:
Open access guideline for pharma about using social media: V3 August 31, 2011
Posted by Dr. Bertalan Meskó in Medicine, Medicine 2.0, Pharma, Web 2.0, Webicina.add a comment
If you follow Scienceroll.com, you know we have been working on a collaborative open access guide for pharma about using social media since May. Here are the Q&As about the project. As we are approaching the end of August, it’s time to insert the final thoughts, comments and additional links about positive and negative examples for pharma using social media channels because we should have the first draft of the guides by the end of September. I hope you join us!
Facebook comments, Pharma and the hard days August 25, 2011
Posted by Dr. Bertalan Meskó in Facebook, Pharma, Video, Web 2.0.1 comment so far
The 15th of August was a special day as that day all pharma Facebook pages had to open the doors to comments which led to some interesting issues and consequences. I thought I would wait some days before writing my post so then it would be easier to see the reactions from the top pharma companies. Well, here are a few examples:
From Lady Gaga and Facebook to MD Celebs and Twitter August 1, 2011
Posted by Dr. Bertalan Meskó in Fun, Pharma, science, Video, Web 2.0, What's on the web?.add a comment
- A great post about how to get Beyond Bullet Points in Medical Education
- Although the British Medical Association has recently warned against patient Facebook requests, here is a story about how Facebook saved a boy’s life
Slate has a dramatic story of how a mother’s Facebook network helped spot – rapidly – Kawasaki Disease, a rare auto-immune disease that the family’s doctors had initially missed. Her social network contains some medically knowledgeable people. (Do you have any docs, nurses, etc in your Facebook circle?) Note that friends’ availability is sometimes far greater than a doctor’s office.
- Interviews about Pharmaceutical communication in a multi-regulatory world
But what’s crazy is that number of Facebook page likes is strongly correlated with the total number of citations a journal has received (r = 0.78, p = 0.001)!
- Phil Baumann’s 140 Healthcare uses for Twitter slideshow:
- And the best blog entry of the week award goes to: Social Media and Pharmaceutical Self-Promotion; A Bad Cocktail or Public Health Service?
We want a radical rethink of what pharmaceutical companies should be doing as part of their social media strategies.
It’s not enough to blast posts and promos to your facebook page and call it social media.
It’s not enough to stream press releases and stock prices to your Twitter accounts.
It’s not enough to build another patient support community and then stifle the “conversation” with moderation.
It’s not enough to continue the PR-broadcast mentality and call it “social media”
Like this:
Open access social media guide for pharma: Q&A July 21, 2011
Posted by Dr. Bertalan Meskó in Pharma, Web 2.0.3 comments
You may have heard about my open access social media guide for pharma project which we hope you will join soon! I discussed the project with Mark Senak at Eye on FDA and he advised me to create a Q&A so then people can clearly see how they can join.
- Why do we need a social media guideline for pharma? Why open access?
FDA doesn’t seem to be ready to give us clear instructions about how pharma can or shouldn’t use social media. So we, pharma bloggers and social media faces behind major pharma companies, should create a draft that the FDA and other companies could use for free. It must be open access so then each company can take it and make it customized based on their own preferences.
- Who can participate in this?
Anyone who is interested. To be able to edit the document, please send me an e-mail.
- What happens in this round (until the end of July)?
Now, we need negative and positive examples of pharma using social media platforms (Twitter, Facebook, Youtube, blogs, Wikipedia, etc).
- How can I help?
Let me know if you would like to participate and then please add your favourite case studies, cases, examples, stories about pharma using different social media platforms in a positive or negative way.
- Who can use the guide when it is ready or what will happen with that?
Anyone can use that for free.
- Do I get credit for my contribution?
Yes, all editors will be listed as ocntributors when we finished the draft.
